January/February 2012
Issue
Cover Focus
Onabotulinumtoxin A for Headache: An Update
A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.
By Michael J. Marmura, MD
FEATURE STORY
Sports Concussion and the Clinical Neurologist, Part III
The third and final installment in a series on sports concussion explores treatment and the role of the neurologist.
By Francis X. Conidi, DO, MS
Hemicrania Continua: A Question and Answer Review
A headache specialist explores the incidence, diagnosis, and treatment of this frequently misdiagnosed headache type.
By Randolph W. Evans, MD
DEPARTMENTS
Dementia Insights:
Short- and Long-Term Cognitive Consequences of Acute Non-Neurological Hospitalization
Most neurologists are not surprised to hear that a patient has cognitively or physically deteriorated after hospitalization, but what is the evidence and mechanism for this?
By Ronald Devere, MD
Top 5 Articles From February 2012
Hemicrania Continua: A Question and Answer Review
A headache specialist explores the incidence, diagnosis, and treatment of this frequently misdiagnosed headache type.
By Randolph W. Evans, MD
Sports Concussion and the Clinical Neurologist, Part III
The third and final installment in a series on sports concussion explores treatment and the role of the neurologist.
By Francis X. Conidi, DO, MS
Dementia Insights:
Short- and Long-Term Cognitive Consequences of Acute Non-Neurological Hospitalization
Most neurologists are not surprised to hear that a patient has cognitively or physically deteriorated after hospitalization, but what is the evidence and mechanism for this?
By Ronald Devere, MD
Onabotulinumtoxin A for Headache: An Update
A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.
